Did you miss us at the 18-ICML?

If so, you can contact us. Our team members will be pleased to talk to you.

Step into the light of innovation by browsing through the slides from the BeOne-sponsored Satellite Symposium, where a faculty of experts unlocked new perspectives in lymphoma care.

This session provided attendees with the opportunity to increase their understanding of:

• The latest advancements in Bruton’s tyrosine kinase inhibitor (BTKi)-based therapeutic options for chronic lymphocytic leukemia (CLL)
• Current and emerging treatment strategies for Waldenström’s macroglobulinemia (WM), from BTKi monotherapies to promising combinations
• The evolving role and future potential of BTKis in mantle cell lymphoma (MCL) and marginal zone lymphoma (MZL)
• BTK protein degraders as a promising new approach to the treatment of lymphomas

The webcast will be available shortly. Please revisit this page soon to access the recording.